Forbes article: VRTX acquires small company, that
Post# of 72433
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Sounds like the IPIX story, we get PYMX's Brilacidin for 5 million bucks, and now it's becoming very important. (Not that Prurisol and Kevetrin are not, but this is a similar case of the tail ending up wagging the dog)
Very good read, will resonate with IPIX shareholders.
https://www.forbes.com/sites/matthewherper/20...626dff5de1
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)